maintaining weight loss after glp-1 New research is taking a closer look at what can happen a year or more people stop taking medications Life After GLP-1: Stop Rebound

Many strategies focus on weight loss alone, ignoring the balance between fat reduction, muscle retention, and metabolic efficiency

By combining incretin-mediated glucose regulation with glucagon-mediated lipid oxidation, multi-receptor agonists may help restore a more flexible metabolic state

Because activation of mGluRs is known to confer neuroprotection by limiting glutamate-induced excitotoxicity [102107], aspartates apparent failure to activate these receptors would leave this protective mechanism unengaged

That list governs which raw substances state-licensed compounding pharmacies may legally use when preparing a medicine against an individual prescription

doi: 10.1007/s00408-020-00342-5, 5

Oncotarget 7 , 4349243503 (2016)